Purchase Order 36C25619P1578

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,131.67 delivery order to Catalyst Pharmaceuticals, Inc. for FIRDAPSE 10MG. The order was placed against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB), with a firm fixed price and performance location in Miami, Florida. No set-aside designation was used for this order to supply the drug FIRDAPSE to the agency, which provides healthcare services to...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $29,916.56 delivery order to Catalyst Pharmaceuticals, Inc. for the pharmaceutical FIRDAPSE. The order was placed against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), a multiple award schedule contract vehicle, with firm fixed pricing. Performance will take place in West Haven, Connecticut by April 30, 2021. No set aside provision was utilized for this order to supply...

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $27,789.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Firdapse 10 mg tablets (10 tablets per package) and does not have a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which...

This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $93,876.04 firm fixed-price delivery order is for the supply of FIRDAPSE 10 MG TABLET 10S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,646 delivery order to Catalyst Pharmaceuticals, Inc. for AMIFAMPRIDINE (FIRDAPSE) 10MG pharmaceutical products. The firm fixed price order was placed against Catalyst Pharmaceuticals' GSA Schedule contract for Pharmaceuticals and Drugs, with performance taking place in Bartlett, Tennessee. No set-aside designation was applied to this order to fulfill VHA medication needs as...

This is a firm fixed-price delivery order award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,393.45 award is for the supply of FIRDAPSE 10 MG TABLET 10S, a specialized prescription drug product, to the Defense Logistics Agency (DLA) under the SPE2DX program. The award is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure...

Catalyst Pharmaceuticals, Inc. was awarded a delivery order valued at $18,978.13 by Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the Department of Veterans Affairs, for the supply of Firdapse 10 mg tablets. This contract, effective December 17, 2025, with an ultimate completion date of December 19, 2025, operates under a firm fixed-price model and carries no set-aside designation. The award is placed against the Pharmaceuticals and Drugs Federal Supply Schedule...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $154,859.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule to Catalyst Pharmaceuticals, Inc. for the provision of 10mg Firdapse (amifampridine) tablets. The order is for a firm fixed price and has a period of performance through October 31, 2022. The Pharmaceuticals and Drugs schedule, managed by GSA, provides government agencies access to...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on February 13, 2025, for the supply of Fycompa 4 mg tablets (30-count units) with a ceiling value of $1,837.44. This firm fixed-price delivery order, which is expected to be completed by February 14, 2025, represents a non-competitive set-aside award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Fycompa (perampanel) is an oral anticonvulsant medication used...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Fycompa 4 mg tablets (30-count) at a fixed price of $1,668.35. This competitively awarded, non-set-aside contract is scheduled for completion by December 17, 2025, with performance to be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. Fycompa (perampanel) is a neurological medication used primarily as an adjunctive treatment for certain seizure...